Chinese combination creates 'leading global biotherapeutics company'

2 January 2019

A merger of two Chinese firms will create what they claim will be a world-class biotherapeutics company.

HJB and MabSpace Biosciences have announced that they have entered into a definitive merger agreement to create Transcenta Holding.

The combined entity will have fully-integrated capabilities in research, development, regulatory and manufacturing of biologics, and will be led by Xueming Qian, the founder, chairman and chief executive of MabSpace, with HJB boss Jonathan Yining Zhao named Transcenta’s executive chairman.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK